![](https://www.bjbms.org/images/26_years_vert_v2.jpg)
![Biomol Biomed IF and CiteScore](https://www.bjbms.org/images/IF.jpg)
is excited to announce a call for papers for our upcoming special issue focusing on Cell-Based Therapeutics. This issue aims to showcase the transformative impacts of cell-based therapies on clinical practice and the pharmaceutical industry, featuring innovative treatments like genetically reprogrammed T cells for lymphoid cancers and adipose-derived stem cells for Crohn’s disease.
Our goal is to bridge the gap between basic and clinical research, enhancing the translation of groundbreaking research into clinical applications. We are looking for submissions that discuss novel methods in cell collection, isolation, modification, and production, as well as clinical applications focusing on safety, efficacy, and regulatory compliance.
Submissions should demonstrate originality, relevance to genetic research and biotechnological applications, rigorous methodology, and compliance with ethical standards.
Submission Period: 15 June to 15 December 2024
Instructions for submitting the article
1. Write a Cover Letter:
- State that you are submitting your article for the special issue on Cell-Based Therapies.
2. Select the correct Section
- When submitting your article, choose the "Special Issue" section. This is the first option on the list.
3. Submit your article
- Follow the steps on this link to submit your article: Submit your article
Join us in advancing the field of cell-based therapies by contributing your groundbreaking research to this special issue. Your work will be handled by well-known experts in the field, ensuring thorough review and wide recognition.